Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07021742

BioHealx® Anal Fistula Device Post Market Surveillance Study

Sponsor: Signum Surgical USA Inc.

View on ClinicalTrials.gov

Summary

This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2025-06-14

Completion Date

2026-12

Last Updated

2026-04-08

Healthy Volunteers

No

Conditions

Interventions

DEVICE

BioHealx

Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device, a bioabsorbable implant designed to securely close the fistula internal opening, preventing reinfection, while allowing for drainage through the external opening during healing.

Locations (5)

The Colorectal Institute

Fort Myers, Florida, United States

Weill Cornell Medicine

New York, New York, United States

Northwell Health

Staten Island, New York, United States

Maininle Health Lankenau

Bryn Mawr, Pennsylvania, United States

Geisinger

Danville, Pennsylvania, United States